IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2

被引:0
|
作者
Zhu, XD
Jacobs, B
Boetticher, E
Myou, S
Meliton, A
Sano, H
Lambertino, AT
Muñoz, NM
Leff, AR
机构
[1] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Neurobiol Pharmacol & Physiol Pediat Anesthe, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Clin Pharmacol Cell Physiol & Mol Med, Div Biol Sci, Chicago, IL 60637 USA
[4] Tottori Univ, Dept Internal Med 3, Tottori, Japan
关键词
adhesion molecules; signal transduction; arachidonic acid;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined the mechanism by which interleukin (IL)-5 causes beta(2)-integrin adhesion of human eosinophils. IL-5 caused time-dependent activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38alpha in eosinophils as detected by their phosphorylation. Preincubation of eosinophils with U0126, a mitogen-activated protein kinase/ERK kinase inhibitor, suppressed IL-5-induced activation of cytosolic phospholipase A(2) (cPLA(2)) and eosinophil adhesion, and p38 inhibition by SB203580 had neither effect. ERK1/2 phosphorylation and eosinophil adhesion were blocked by inhibition of the src-family tyrosine kinase, Janus tyrosine kinase (JAK)2, or phosphoinositide-3 kinase (PI3K). Coimmunoprecipitation assay demonstrated that Lyn, a src-family tyrosine kinase, was constitutively associated with PI3K. Inhibition of src-tyrosine kinase but not JAK2 suppressed PI3K activation. Our data suggest that IL-5 induces beta(2)-integrin adhesion of human eosinophils by regulation of cPLA2 activation caused by ERK1/2 phosphorylation. This phosphorylation results from activation of PI3K and protein tyrosine kinases. We also find that src-family tyrosine kinase, possibly Lyn, is the upstream kinase causing PI3K activation.
引用
收藏
页码:1046 / 1053
页数:8
相关论文
共 50 条
  • [1] IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells
    Lee, Eo-Jin
    Park, Sung-Soo
    Kim, Wun-Jae
    Moon, Sung-Kwon
    ONCOLOGY REPORTS, 2012, 28 (03) : 1084 - 1090
  • [2] Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
    Pitson, SM
    Moretti, PAB
    Zebol, JR
    Lynn, HE
    Xia, P
    Vadas, MA
    Wattenberg, BW
    EMBO JOURNAL, 2003, 22 (20): : 5491 - 5500
  • [3] Regulation of adhesion of AML14.3D10 cells by surface clustering of β2-integrin caused by ERK-independent activation of cPLA2
    Myou, S
    Zhu, XD
    Boetticher, E
    Qin, YM
    Myo, S
    Meliton, A
    Lambertino, A
    Munoz, NM
    Hamann, KJ
    Leff, AR
    IMMUNOLOGY, 2002, 107 (01) : 77 - 85
  • [4] Activation of ERK1/2 and cPLA2 by the p55 TNF receptor occurs independently of FAN
    Lüschen, S
    Adam, D
    Ussat, S
    Kreder, D
    Schneider-Brachert, W
    Krönke, M
    Adam-Klages, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (02) : 506 - 512
  • [5] Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium
    Xu, Chong
    Zhang, Hai
    Liu, Chunxiao
    Zhu, Yu
    Wang, Xiaoxue
    Gao, Wei
    Huang, Shile
    Chen, Long
    ONCOTARGET, 2015, 6 (25) : 21452 - 21467
  • [6] Cyclic stretch-induced cPLA2 mediated release of arachidonic acid is an effector of ERK1/2 signaling in rabbit proximal tubule cells
    Alexander, LD
    Alagarsami, S
    Douglas, JG
    FASEB JOURNAL, 2004, 18 (05): : A1021 - A1021
  • [7] β2-Integrin adhesion caused by eotaxin but not IL-5 is blocked by PDE-4 inhibition and β2-adrenoceptor activation in human eosinophils
    Liu, J
    Muñoz, NM
    Meliton, AY
    Zhu, XD
    Lambertino, AT
    Xu, C
    Myo, S
    Myou, S
    Boetticher, E
    Johnson, M
    Leff, AR
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2004, 17 (02) : 73 - 79
  • [8] Cycloheximide-induced cPLA2 activation is via the MKP-1 down-regulation and ERK activation
    Lin, WW
    Hsu, YW
    CELLULAR SIGNALLING, 2000, 12 (07) : 457 - 461
  • [9] Particle induced Erk1/2 and AKT signalling is mediated by β1-integrin
    Bierhals, K
    Berken, A
    Abel, J
    Unfried, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R131 - R131
  • [10] Monomeric ERK2 attenuates ERK1/2-mediated pathological cardiac hypertrophy
    Tomasovic, Angela
    Huemmert, Martin
    Ruppert, Catharina
    Lohse, Martin J.
    Lorenz, Kristina
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S20 - S20